Cervical Cancer - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe
PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter Blog Tech …

Background Preoperative neoadjuvant chemotherapy (NACT) has been widely used in
developing countries for the treatment of patients with International Federation of …

Background Cervical carcinoma is one of the most prevalent cancers affecting women
worldwide. Studies on Ki-67 expression in cervical lesions had focused mainly on the …

Background: Cervical cancer, the most common gynecological cancer, is a matter of
concern, especially in developing countries. The present study investigates survival rates …

Introduction: Cervical cancer is among the most frequent types of neoplasia worldwide and
remains the fourth leading cause of cancer death in women, a fact that raises the necessity …

Background Cervical cancer is a tumor with high morbidity and mortality. The importance of
inflammatory and metabolic parameters affecting progression-free survival (PFS) and overall …

Cervical cancer continues to be listed among the top gynecologic cancers worldwide.
According to current data, it is ranked fourteenth among all cancers and fourth-ranked …

Objective Cervical cancer is a common gynecological malignancy. However, the optimal
surgical approach and benefits of uterine manipulator use remain unclear in this context …

Gynecological cancers are the most prevalent cancers in women, making them a major
public health concern for decades. Health disparities and inequalities in access to care …

Purpose Contemporary, real-world data on eligible patients receiving treatment following
progression on first-line (1L) recurrent or metastatic cervical cancer (r/mCC) therapy are …